Audentes Therapeutics Inc (OQ:BOLD)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for BOLD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 20th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 13/19 Prasad Suyash Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
May 15/19 May 13/19 Prasad Suyash Direct Ownership Common Stock S - Open market or private sale -54 $37.72
May 15/19 May 13/19 Prasad Suyash Direct Ownership Common Stock S - Open market or private sale -9,946 $36.98
May 15/19 May 13/19 Prasad Suyash Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $0.790
Apr 1/19 Apr 1/19 Meltz Mark A Direct Ownership No securities beneficially held Form 3 : Initial Statement of Beneficial Ownership of Securities    
Apr 1/19 Mar 28/19 Meltz Mark A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 104,000  
Apr 1/19 Mar 28/19 Meltz Mark A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 37,333  
Mar 27/19 Mar 25/19 Lange Louis G Indirect Ownership Common Stock S - Open market or private sale -558 $35.94
Mar 27/19 Mar 25/19 Lange Louis G Indirect Ownership Common Stock S - Open market or private sale -1,000 $36.00
Mar 27/19 Mar 25/19 Lange Louis G Direct Ownership Common Stock S - Open market or private sale -300 $36.64
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BOLD within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 20th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 15/19 May 13/19 Prasad Suyash Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
May 15/19 May 13/19 Prasad Suyash Direct Ownership Common Stock S - Open market or private sale -54 $37.72
May 15/19 May 13/19 Prasad Suyash Direct Ownership Common Stock S - Open market or private sale -9,946 $36.98
May 15/19 May 13/19 Prasad Suyash Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $0.790
Apr 1/19 Mar 28/19 Meltz Mark A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 104,000  
Apr 1/19 Mar 28/19 Meltz Mark A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 37,333  
Apr 1/19 Apr 1/19 Meltz Mark A Direct Ownership No securities beneficially held Form 3 : Initial Statement of Beneficial Ownership of Securities    
Mar 27/19 Mar 25/19 Lange Louis G Indirect Ownership Common Stock S - Open market or private sale -558 $35.94
Mar 27/19 Mar 25/19 Lange Louis G Indirect Ownership Common Stock S - Open market or private sale -1,000 $36.00
Mar 27/19 Mar 25/19 Lange Louis G Direct Ownership Common Stock S - Open market or private sale -300 $36.64
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $BOLD

StockTwits